Free tool
Healthcare stocks
We cover 108 companies in the Healthcare sector. The median market value in the group is $814.95M. Across the group, the median move over the past trading day is 0.00%. 94% of the 107 with a 200-day average trade above it. Price change over the past year runs from −25.6% to +300.5% across the middle 80 percent of the group, with a median of +61.6%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
108 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% |
| BDX | Becton, Dickinson and Company | $190.21 | +14.35% | +24.91% | +25.97% |
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% |
| IQV | IQVIA Holdings Inc. | $261.51 | +7.64% | +16.04% | +38.51% |
| ILMN | Illumina, Inc. | $224.84 | +16.51% | +67.35% | +125.88% |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% |
| CRL | Charles River Laboratories International, Inc. | $295.10 | +22.74% | +45.79% | +81.27% |
| HALO | Halozyme Therapeutics, Inc. | $107.06 | +28.29% | +52.27% | +46.30% |
| BIO | Bio-Rad Laboratories, Inc. | $388.64 | +17.41% | +27.31% | +32.71% |
| RGEN | Repligen Corporation | $180.30 | +24.05% | +9.70% | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $134.95 | +0.58% | +78.08% | +257.11% |
| BIO-B | Bio-Rad Laboratories, Inc. | $365.08 | +18.01% | +17.50% | +47.78% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +143.24% |
| HAE | Haemonetics Corporation | $106.60 | +29.15% | +33.28% | +93.71% |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% |
| ITGR | Integer Holdings Corporation | $125.19 | +24.72% | +63.05% | +15.84% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.08 | +89.67% | +224.69% | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +55.97% |
| OGN | Organon & Co. | $13.77 | +1.85% | +90.95% | +50.67% |
| PLSE | Pulse Biosciences, Inc. | $48.10 | +35.61% | +259.22% | +203.47% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $8.90 | +29.74% | +161.76% | +281.97% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% |
| ZLAB | Zai Lab Limited | $26.03 | +39.80% | +50.20% | −20.06% |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% |
| PRGO | Perrigo Company plc | $14.76 | +43.30% | +8.65% | −36.05% |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% |
| ETON | Eton Pharmaceuticals, Inc. | $62.62 | +34.20% | +285.12% | +262.38% |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% |
| SPTX | Seaport Therapeutics, Inc. | $27.84 | +39.90% | +40.32% | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $36.53 | +33.22% | +120.19% | +786.65% |
| OMER | Omeros Corporation | $18.22 | +61.52% | +11.23% | +328.71% |
| CRON | Cronos Group Inc. | $3.55 | +24.56% | +31.48% | +38.67% |
| JANX | Janux Therapeutics, Inc. | $18.89 | +25.93% | +38.39% | −19.10% |
| IMMX | Immix Biopharma, Inc. | $14.07 | +66.71% | +159.12% | +617.86% |
| HELP | Cybin D/B/A Helus Pharma | $13.63 | +79.34% | +64.61% | +77.71% |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% |
| VREX | Varex Imaging Corporation | $18.48 | +66.04% | +58.63% | +61.40% |
| SOPH | SOPHiA GENETICS SA | $8.53 | +53.14% | +82.66% | +156.16% |
| ASMB | Assembly Biosciences, Inc. | $35.42 | +38.52% | +4.95% | +36.81% |
| OABI | OmniAb, Inc. | $4.81 | +144.16% | +155.85% | +198.76% |
| AQST | Aquestive Therapeutics, Inc. | $5.39 | +43.35% | −16.43% | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% |
| SENS | Senseonics Holdings, Inc. | $9.34 | +90.22% | +58.57% | +0.43% |
| SGHT | Sight Sciences, Inc. | $8.37 | +57.92% | +11.90% | +97.87% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $15.83 | +175.30% | +153.28% | −8.44% |
| MCTA | Charming Medical Limited | $29.36 | 0.00% | 0.00% | +319.36% |
| CARL | Carlsmed, Inc. | $16.18 | +31.44% | +39.12% | +16.40% |
| CCRN | Cross Country Healthcare Inc | $13.25 | 0.00% | +64.39% | +0.38% |
| TBRG | TruBridge Inc | $26.24 | 0.00% | +25.55% | +30.42% |
| RCEL | AVITA Medical, Inc. | $10.59 | +129.72% | +205.19% | +133.77% |
| SMTI | Sanara MedTech Inc. | $34.65 | +30.07% | +50.00% | +2.09% |
| YDES | YD Bio Ltd | $4.34 | +88.70% | −63.83% | −63.83% |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% |
| ACB | Aurora Cannabis Inc. | $4.00 | +47.06% | −7.83% | −24.95% |
| CRDL | Cardiol Therapeutics Inc. | $2.14 | +78.33% | +115.29% | +91.07% |
| NGEN | NervGen Pharma Corp. | $2.21 | +37.27% | −62.41% | −8.30% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.30 | +24.38% | +43.58% | +7.93% |
| ORMP | Oramed Pharmaceuticals Inc. | $5.34 | +28.06% | +96.84% | +159.19% |
| XGN | Exagen Inc. | $7.67 | +72.36% | +26.99% | −19.69% |
| SPRB | Spruce Biosciences, Inc. | $61.48 | +47.79% | −32.22% | +721.93% |
| ASRT | Assertio Holdings Inc | $23.50 | 0.00% | +157.11% | +103.46% |
| EMPG | Empro Group Inc | $17.36 | 0.00% | 0.00% | +76.60% |
| CPIX | Cumberland Pharmaceuticals Inc. | $8.97 | +69.86% | +125.38% | +163.82% |
| BMEA | Biomea Fusion, Inc. | $1.71 | +36.80% | +27.61% | −8.06% |
| LUNG | Pulmonx Corporation | $2.50 | +100.00% | +8.70% | +34.41% |
| DWTX | Dogwood Therapeutics, Inc. | $2.66 | +71.61% | −37.26% | −42.80% |
| INCR | InterCure Ltd. | $5.95 | +546.74% | +477.67% | +265.03% |
| INMB | INmune Bio Inc. | $2.45 | +42.98% | +58.77% | +19.56% |
| PRPO | Precipio, Inc. | $30.41 | +34.12% | +27.64% | +99.25% |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% |
| HBIO | Harvard Bioscience, Inc. | $7.65 | +29.22% | +17.69% | +44.34% |
| KYNB | Kyntra Bio, Inc. | $8.11 | +16.20% | −11.52% | −22.66% |
| TXMD | TherapeuticsMD, Inc. | $2.28 | +10.68% | +38.18% | +103.57% |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% |
| PMI | Picard Medical, Inc. | $9.80 | +122.73% | +438.46% | +113.51% |
| VYNE | VYNE Therapeutics Inc | $28.56 | +3080.40% | +4824.14% | +8660.74% |
| LEXX | Lexaria Bioscience Corp. | $11.04 | +36.30% | +1588.07% | +1146.05% |
| BCDA | BioCardia, Inc. | $1.19 | +52.56% | −6.30% | −38.66% |
| CMMB | Chemomab Therapeutics Ltd. | $2.59 | +81.12% | +44.69% | −25.57% |
| APRE | Aprea Therapeutics, Inc. | $0.98 | +59.61% | +14.89% | −38.75% |
| LUCY | Lucyd, Inc | $1.13 | +52.50% | −0.88% | −42.05% |
| FBLG | FibroBiologics, Inc. | $1.41 | +116.92% | −70.62% | −88.25% |
| XBIO | Xenetic Biosciences, Inc. | $3.86 | +54.40% | +79.53% | +35.92% |
| SKYE | Skye Bioscience, Inc. | $2.02 | +228.46% | +130.07% | −41.62% |
| CURX | Curanex Pharmaceuticals Inc | $4.60 | +2223.23% | +1150.00% | −1.29% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.33 | +710.86% | +426.12% | +211.51% |
| BIAF | bioAffinity Technologies, Inc. | $5.09 | +710.51% | +317.21% | −31.59% |
| SCNI | Scinai Immunotherapeutics Ltd. | $2.87 | +987.12% | +293.15% | +93.92% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.